Blandt de patienter, som ikke havde respons i uge 4, responderede 43% af patienterne i Trudexa vedligeholdelsesbehandling ved uge 12 sammenlignet med 30% af patienter i placebogruppen.
Among patients who were not in response at week 4, 43% of Trudexa maintenance patients responded by week 12 compared to 30% of placebo maintenance patients.